| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |